Cargando…

Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment

Uveal melanoma (UM) is characterized by a number of genetic aberrations that follow a certain chronology and are tightly linked to tumor recurrence and survival. Loss of chromosome 3, bi-allelic loss of BAP1 expression, and gain in chromosome 8q have been associated with metastasis formation and dea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gezgin, Gülçin, Dogrusöz, Mehmet, van Essen, T. Huibertus, Kroes, Wilhelmina G. M., Luyten, Gregorius P. M., van der Velden, Pieter A., Walter, Vonn, Verdijk, Robert M., van Hall, Thorbald, van der Burg, Sjoerd H., Jager, Martine J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489616/ https://www.ncbi.nlm.nih.gov/pubmed/28391358 http://dx.doi.org/10.1007/s00262-017-1991-1

Ejemplares similares

Ischemia Is Related to Tumour Genetics in Uveal Melanoma
por: Brouwer, Niels J., et al.
Publicado: (2019)

Tumour Angiogenesis in Uveal Melanoma Is Related to Genetic Evolution
por: Brouwer, Niels J., et al.
Publicado: (2019)

Upregulation of HLA Expression in Primary Uveal Melanoma by Infiltrating Leukocytes
por: van Essen, T. Huibertus, et al.
Publicado: (2016)

Heterogeneity revealed by integrated genomic analysis uncovers a molecular switch in malignant uveal melanoma
por: de Lange, Mark J., et al.
Publicado: (2015)

Tumor-Infiltrating T Cells Can Be Expanded Successfully from Primary Uveal Melanoma after Separation from Their Tumor Environment
por: Gezgin, Gülçin, et al.
Publicado: (2022)

Do GNAQ and GNA11 Differentially Affect Inflammation and HLA Expression in Uveal Melanoma?
por: van Weeghel, Christiaan, et al.
Publicado: (2019)

Microphthalmia-Associated Transcription Factor: A Differentiation Marker in Uveal Melanoma
por: Gelmi, Maria Chiara, et al.
Publicado: (2023)

LAG3 and Its Ligands Show Increased Expression in High-Risk Uveal Melanoma
por: Souri, Zahra, et al.
Publicado: (2021)

Loss of BAP1 Is Associated with Upregulation of the NFkB Pathway and Increased HLA Class I Expression in Uveal Melanoma
por: Souri, Zahra, et al.
Publicado: (2019)

Expression of HDACs 1, 3 and 8 Is Upregulated in the Presence of Infiltrating Lymphocytes in Uveal Melanoma
por: Souri, Zahra, et al.
Publicado: (2021)

Prognostic Factors Five Years After Enucleation for Uveal Melanoma
por: Dogrusöz, Mehmet, et al.
Publicado: (2020)

HDAC Inhibition Increases HLA Class I Expression in Uveal Melanoma
por: Souri, Zahra, et al.
Publicado: (2020)

Soluble HLA in the Aqueous Humour of Uveal Melanoma Is Associated with Unfavourable Tumour Characteristics
por: Wierenga, Annemijn P. A., et al.
Publicado: (2019)

MiRNAs Correlate with HLA Expression in Uveal Melanoma: Both Up- and Downregulation Are Related to Monosomy 3
por: Souri, Zahra, et al.
Publicado: (2021)

Involvement of mutant and wild-type CYSLTR2 in the development and progression of uveal nevi and melanoma
por: Nell, Rogier J., et al.
Publicado: (2021)

Differential Expression of DNA Repair Genes in Prognostically-Favorable versus Unfavorable Uveal Melanoma
por: Dogrusöz, Mehmet, et al.
Publicado: (2019)

In Uveal Melanoma, Angiopoietin-2 but Not Angiopoietin-1 Is Increased in High-Risk Tumors, Providing a Potential Druggable Target
por: ten Voorde, Anna M.W., et al.
Publicado: (2021)

EMT-associated factors promote invasive properties of uveal melanoma cells
por: Asnaghi, Laura, et al.
Publicado: (2015)

Distribution of GNAQ and GNA11 Mutation Signatures in Uveal Melanoma Points to a Light Dependent Mutation Mechanism
por: de Lange, Mark J., et al.
Publicado: (2015)

Increased Histological Tumor Pigmentation in Uveal Melanoma Is Related to Eye Color and Loss of Chromosome 3/BAP1
por: Gelmi, Maria Chiara, et al.
Publicado: (2023)

Targeting of the MAPK and AKT pathways in conjunctival melanoma shows potential synergy
por: Cao, Jinfeng, et al.
Publicado: (2016)

Digital PCR Validates 8q Dosage as Prognostic Tool in Uveal Melanoma
por: Versluis, Mieke, et al.
Publicado: (2015)

MR imaging characteristics of uveal melanoma with histopathological validation
por: Ferreira, Teresa A., et al.
Publicado: (2021)

Iris Colour and the Risk of Developing Uveal Melanoma
por: Houtzagers, Laurien E., et al.
Publicado: (2020)

Triamcinolone acetonide and anecortave acetate do not stimulate uveal melanoma cell growth
por: el Filali, Mariam, et al.
Publicado: (2008)

Uveal Versus Cutaneous Melanoma; Same Origin, Very Distinct Tumor Types
por: van der Kooij, Monique K., et al.
Publicado: (2019)

Inhibition of CSF-1R Supports T-Cell Mediated Melanoma Therapy
por: Sluijter, Marjolein, et al.
Publicado: (2014)

Bevacizumab and intraocular tumors: an intriguing paradox
por: el Filali, Mariam, et al.
Publicado: (2012)

Clinical Outcomes after International Referral of Uveal Melanoma Patients for Proton Therapy
por: Marinkovic, Marina, et al.
Publicado: (2021)

Episodic Src activation in uveal melanoma revealed by kinase activity profiling
por: Maat, W, et al.
Publicado: (2009)

TEIPP peptides: exploration of unTAPped cancer antigens
por: Marijt, Koen A., et al.
Publicado: (2019)

Targeting the YAP/TAZ Pathway in Uveal and Conjunctival Melanoma With Verteporfin
por: Brouwer, Niels J., et al.
Publicado: (2021)

Future Challenges in Cancer Resistance to Immunotherapy
por: van Elsas, Marit J., et al.
Publicado: (2020)

Scientific and clinical implications of genetic and cellular heterogeneity in uveal melanoma
por: de Lange, Mark J., et al.
Publicado: (2021)

The Economic Value of MR-Imaging for Uveal Melanoma
por: Grech Fonk, Lorna, et al.
Publicado: (2020)

Cross-presentation of a TAP-independent signal peptide induces CD8 T immunity to escaped cancers but necessitates anchor replacement
por: Marijt, Koen A., et al.
Publicado: (2021)

Preconditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy
por: Groeneveldt, Christianne, et al.
Publicado: (2020)

The positive prognostic effect of stromal CD8+ tumor-infiltrating T cells is restrained by the expression of HLA-E in non-small cell lung carcinoma
por: Yazdi, Mehrdad Talebian, et al.
Publicado: (2015)

Patients presenting with metastases: stage IV uveal melanoma, an international study
por: Garg, Gaurav, et al.
Publicado: (2022)

T cells specific for a TAP-independent self-peptide remain naïve in tumor-bearing mice and are fully exploitable for therapy
por: Doorduijn, Elien M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1gqup0nl2d8fddqbr9kmoctous